Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients
- 1 March 2013
- journal article
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 45 (3), 245-250
- https://doi.org/10.1016/j.dld.2012.09.013
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX ChemotherapyClinical Cancer Research, 2011
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant TherapyJNCI Journal of the National Cancer Institute, 2011
- A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot studyCritical Reviews in Oncology/Hematology, 2011
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerJournal of Clinical Oncology, 2010
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon CancerClinical Cancer Research, 2008
- Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative StudyJournal of Clinical Oncology, 2007
- Systematic Review of Microsatellite Instability and Colorectal Cancer PrognosisJournal of Clinical Oncology, 2005
- Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomasInternational Journal of Cancer, 2003
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsThe New England Journal of Medicine, 2001
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaThe New England Journal of Medicine, 1990